Literature DB >> 17176168

Peripheral neuropathy: pathogenic mechanisms and alternative therapies.

Kathleen A Head1.   

Abstract

Peripheral neuropathy (PN), associated with diabetes, neurotoxic chemotherapy, human immunodeficiency virus (HIV)/antiretroviral drugs, alcoholism, nutrient deficiencies, heavy metal toxicity, and other etiologies, results in significant morbidity. Conventional pain medications primarily mask symptoms and have significant side effects and addiction profiles. However, a widening body of research indicates alternative medicine may offer significant benefit to this patient population. Alpha-lipoic acid, acetyl-L-carnitine, benfotiamine, methylcobalamin, and topical capsaicin are among the most well-researched alternative options for the treatment of PN. Other potential nutrient or botanical therapies include vitamin E, glutathione, folate, pyridoxine, biotin, myo-inositol, omega-3 and -6 fatty acids, L-arginine, L-glutamine, taurine, N-acetylcysteine, zinc, magnesium, chromium, and St. John's wort. In the realm of physical medicine, acupuncture, magnetic therapy, and yoga have been found to provide benefit. New cutting-edge conventional therapies, including dual-action peptides, may also hold promise.

Entities:  

Mesh:

Year:  2006        PMID: 17176168

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  39 in total

1.  Pain associated with diabetic peripheral neuropathy: a review of available treatments.

Authors:  Erin L St Onge; Shannon A Miller
Journal:  P T       Date:  2008-03

2.  Diabetes, peripheral neuropathy, and lower-extremity function.

Authors:  Nancy S Chiles; Caroline L Phillips; Stefano Volpato; Stefania Bandinelli; Luigi Ferrucci; Jack M Guralnik; Kushang V Patel
Journal:  J Diabetes Complications       Date:  2013-10-11       Impact factor: 2.852

3.  Methylcobalamine is effective in peripheral neuropathies.

Authors:  S U Naik; D V Sonawane
Journal:  Eur J Clin Nutr       Date:  2015-01-14       Impact factor: 4.016

4.  Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit.

Authors:  Chihiro Nozaki; Angela Maria Vergnano; Dominique Filliol; Abdel-Mouttalib Ouagazzal; Anne Le Goff; Stéphanie Carvalho; David Reiss; Claire Gaveriaux-Ruff; Jacques Neyton; Pierre Paoletti; Brigitte L Kieffer
Journal:  Nat Neurosci       Date:  2011-07-03       Impact factor: 24.884

5.  Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma.

Authors:  John Gerecitano; Carol Portlock; Paul Hamlin; Craig H Moskowitz; Ariela Noy; David Straus; Philip Schulman; Otilia Dumitrescu; Debra Sarasohn; Jennifer Pappanicholaou; Alexia Iasonos; Zhigang Zhang; Qianxing Mo; Endri Horanlli; Celeste N Rojas; Andrew D Zelenetz; Owen A O'Connor
Journal:  Clin Cancer Res       Date:  2011-02-23       Impact factor: 12.531

6.  Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy.

Authors:  Mehmet Kanter
Journal:  Neurochem Res       Date:  2007-08-23       Impact factor: 3.996

7.  Meta-analysis of methylcobalamin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy.

Authors:  Houliang Deng; JinJin Yin; JingJing Zhang; Qian Xu; Xiaoxia Liu; Li Liu; Zhuomin Wu; Aimin Ji
Journal:  Endocrine       Date:  2014-02-13       Impact factor: 3.633

8.  Benfotiamine prevents increased β-amyloid production in HEK cells induced by high glucose.

Authors:  Xiao-Jing Sun; Lei Zhao; Na Zhao; Xiao-Li Pan; Guo-Qiang Fei; Li-Rong Jin; Chun-Jiu Zhong
Journal:  Neurosci Bull       Date:  2012-09-08       Impact factor: 5.203

9.  Association of nerve conduction impairment and insulin resistance in children with obesity.

Authors:  Onur Akın; İbrahim Eker; Mutluay Arslan; Serdar Taşdemir; Mehmet Emre Taşçılar; Ümit Hıdır Ulaş; Ediz Yeşilkaya; Bülent Ünay
Journal:  Childs Nerv Syst       Date:  2016-08-09       Impact factor: 1.475

10.  Yoga Practice for the Management of Type II Diabetes Mellitus in Adults: A systematic review.

Authors:  Badr Aljasir; Maggie Bryson; Bandar Al-Shehri
Journal:  Evid Based Complement Alternat Med       Date:  2008-05-07       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.